GOCM
INSM icon

Green Owl Capital Management’s Insmed INSM Stock Holding History

Green Owl Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-30,000
Closed -$5K – 65
2015
Q4 		$5K Buy
+30,000
New +$529K 0.01% 76

Other funds holding INSM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Green Owl Capital Management's INSM Position: Q2 2016 in Review

Green Owl Capital Management sold out of Insmed (INSM) in Q2 2016, closing a stake of 61,714 shares — an estimated $782K sold.

Green Owl Capital Management first reported a position in INSM in Q4 2014 and held it in 4 quarters. The position peaked at $1.63M in Q4 2015. 106 funds tracked by Wall St. Rank hold INSM as of Q2 2016.

  • Green Owl Capital Management reported no remaining Insmed position as of Q2 2016 after selling out during the quarter.
  • Green Owl Capital Management sold 61,714 Insmed shares in Q2 2016, an estimated $782K.
  • Green Owl Capital Management first reported a position in Insmed in Q4 2014 and held it in 4 quarters.
  • Green Owl Capital Management's Insmed position peaked at $1.63M in Q4 2015.
  • 106 funds tracked by Wall St. Rank held Insmed as of Q2 2016.

Based on Green Owl Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.